查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2136151

晶片式寡核苷酸合成市場：全球市場預測（2026-2032年）

Chip-based Oligonucleotide Synthesis Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，基於晶片的寡核苷酸合成市場將成長至 8,040 萬美元，複合年成長率為 8.83%。

主要市場統計數據
基準年 2025 4445萬美元
預計年份：2026年 4986萬美元
預測年份 2032 8040萬美元
複合年成長率 (%) 8.83%

基於晶片的寡核苷酸合成：概述

基於晶片的寡核苷酸合成技術利用空間可尋址陣列和平行化學處理，以緊湊的形式產生大量不同的核酸序列。此方法適用於需要序列多樣性、快速原型製作、多重檢測、合成生物學工作流程和文庫建構等應用。其策略價值取決於合成保真度、序列長度、化學修飾能力、純化要求、下游製程檢驗以及與自動化和生物資訊學的整合。

並行化正在改變寡核苷酸的開發方式。

該領域正從單一序列的生產轉向高度並行化的數位化工作流程。基於陣列的合成技術支援高密度序列庫的構建，同時減少了一對一生產過程中所需的物理操作。對更快的設計、建造和檢驗週期、更複雜的檢測方法以及可擴展的客製化核酸材料的需求，也推動了這項技術的應用。然而，該技術仍面臨諸多挑戰，包括有效讀取長度縮短、缺失和替換錯誤、批間一致性問題、單一序列的回收率以及對嚴格的品管程序的需求。

人工智慧連接設計、綜合和檢驗。

人工智慧不僅在序列設計階段，而且在整個工作流程中都扮演著日益重要的角色。機器學習技術可以幫助確定候選序列的優先順序、識別問題基序、最佳化密碼子和探針設計，並預測與二級結構和合成相關的風險。人工智慧驅動的實驗室規劃可以提高晶片利用率、樣本追蹤和品管優先級，而序列分析工具則有助於區分技術誤差和生物學變異。可靠的部署仍然需要具有代表性的訓練數據、實驗檢驗、透明的性能指標、網路安全措施以及人工監督。

北美、拉丁美洲、歐洲、中東和非洲以及亞太地區的情況各不相同。

北美受惠於成熟的生物技術基礎設施、強大的產學合作以及先進的實驗室自動化。歐洲擁有強大的研究能力，並對化學、生物學、數據和產品管治有嚴格的要求，其中歐盟尤其重視可追溯性和負責任的創新。亞太地區受益於基因組相關活動的擴展、製造能力的提升和研發投入的增加，但市場准入和監管成熟度存在差異。拉丁美洲正透過大學、診斷項目和農業生物技術發展自身能力，但基礎設施不足和對進口的依賴仍是限制因素。中東正透過國家主導的計劃和專門機構建構基因組學和生命科學能力。非洲在感染疾病監測、農業和本地化研究方面擁有巨大的發展機遇，但實驗室基礎設施的差異、複雜的採購流程以及專家資源的匱乏可能成為限制因素。

群體間的互動塑造了標準、進入和協作。

東南亞國協的科研基礎設施、製造業水準和監管發展程度各不相同，因此區域間的互通性至關重要。金磚國家成員國擁有重要的科學和工業能力，但在採購系統、標準和專用設備的取得方面有顯著差異。歐盟強調管治協調、資料保護和品管系統。七國集團成員國通常擁有先進的科學研究網路、自動化技術和轉換研究能力。海灣合作理事會成員國正在推動基因組學發展、醫療保健現代化並投資科研基礎設施，但本地能力建設仍是關鍵考量。北約成員國可以從現有的​​科學合作和生物安全合作中獲益，但國防相關應用需要謹慎的管治、出口管制考量以及負責任使用的保障措施。

每個國家的優先事項涵蓋了從基礎設施建設到先進轉化研究的各個方面。

美國擁有先進的生物技術研究能力、自動化應用和轉換活動。加拿大在學術基因組學和公共研究網路方面實力雄厚。英國、法國、德國、義大利和西班牙擁有成熟的分子生物學社群、生物製造能力和系統化的法規環境，但其國內實施情況因應用領域而異。中國正在拓展其在基因組研究、實驗室自動化和國內供應鏈方面的能力。日本強調精準性、可靠性和先進的測量儀器，而韓國則將生物技術發展與強大的電子和製造技術相結合。印度正在拓展其在基因組學、診斷和生物技術領域的能力，並專注於經濟性和規模化。澳洲支持基因組研究、農業應用和地理分散的科學網路。巴西和墨西哥正在推動醫療、農業和研究領域的應用開發，但基礎設施和供應鏈韌性仍是一項重大挑戰。俄羅斯在某些分子和生物學領域保持科研能力，但合作、採購和監管條件可能會影響技術的取得。

優先部署注重品質、互通性和用例的方案。

行業領導者應首先關注並行測序在工作流程方面具有明顯優勢的應用領域，並根據既定的準確性、回收率、時間和可重複性標準檢驗其性能。他們還應建立正交的品管方法，記錄序列層面的錯誤情況，並透過可互通的資料標準協調合成、純化、定序和資訊系統。與研究機構和專業自動化供應商建立合作關係可以加速方法檢驗，但管治必須涵蓋智慧財產權、資料安全、生物安全和負責任使用等方面的篩檢。人工智慧投資應與可衡量的實驗室成果掛鉤，並輔以精心整理的資料集、審計追蹤和專家評審。區域運作模式也應考慮試劑供應、服務連續性、監管義務和本地技術培訓。

調查方法：基於證據的技術和運行條件綜合分析。

本執行摘要基於對已記錄的技術特性、應用需求、區域研究環境、政策環境和營運限制的結構化評估，並以提供的市場定義（即基於晶片的寡核苷酸合成）為基礎。分析區分了既有特性和新興應用案例，避免了未經證實的量化聲明。針對區域、群體和國家的具體觀察結果，以定性比較的形式進行總結，比較內容涵蓋基礎設施、科研活動、法規、生產製造和准入因素。關於人工智慧的討論著重於已記錄的工作流程應用和實施要求，而非檢驗的性能聲明。

基於晶片的合成將透過整合和管理的流程而取得進展。

基於晶片的寡核苷酸合成技術有望支援日益複雜化和數位化管理的生物學工作流程。其發展並非主要取決於平行合成本身，而是取決於保真度、序列可重複性、自動化、分析、供應穩定性以及監管保障等方面的協同改進。那些能夠將精心挑選的應用案例與嚴格的檢驗、互操作系統、負責任的人工智慧以及在地化的營運模式相結合的機構，將更有能力將這項技術轉化為可靠的研究和應用成果。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 晶片型寡核苷酸合成市場：依產品類型分類

  • DNA寡核苷酸
  • 修飾寡核苷酸
    • 鎖核酸
    • 嗎啉代寡核苷酸
    • 胜肽核酸
  • RNA寡核苷酸

第8章 晶片式寡核苷酸合成市場：依技術分類

  • 電化學方法
  • 微流體流動方法
  • 光刻
    • 使用掩模的光刻技術
    • 無掩模光刻

第9章：晶片式寡核苷酸合成市場：依應用領域分類

  • 農業生物技術
  • 診斷
  • 基因組學和個人化醫療
    • CRISPR-Cas
    • 微陣列分析
    • 次世代定序
  • 研究與開發
  • 治療

第10章：晶片式寡核苷酸合成市場：依最終用戶分類

  • 學術研究機構
  • 受託研究機構
  • 診斷檢查室
  • 製藥和生物技術公司

第11章 晶片型寡核苷酸合成市場：依規模分類

  • 工業規模
  • 實驗室規模

第12章：晶片式寡核苷酸合成市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 晶片型寡核苷酸合成市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：晶片式寡核苷酸合成市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Agilent Technologies, Inc.
  • BioAutomation, Inc.
  • CustomArray, Inc.
  • Eurofins Genomics GmbH
  • GenScript Biotech Corporation
  • LC Sciences, LLC
  • Merck KGaA
  • Nuclera Nucleics Ltd
  • Roche Sequencing Solutions, Inc.
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation

第17章 主要專家

Product Code: MRR-961F26FD6666

The Chip-based Oligonucleotide Synthesis Market is projected to grow by USD 80.40 million at a CAGR of 8.83% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 44.45 million
Estimated Year [2026] USD 49.86 million
Forecast Year [2032] USD 80.40 million
CAGR (%) 8.83%

Chip-Based Oligonucleotide Synthesis: Executive Overview

Chip-based oligonucleotide synthesis uses spatially addressable arrays and parallel chemical processing to produce many distinct nucleic-acid sequences in a compact format. The approach is relevant to applications requiring sequence diversity, rapid prototyping, multiplexed assays, synthetic biology workflows, and library construction. Its strategic value is shaped by synthesis fidelity, sequence length, chemical modification capability, purification requirements, downstream validation, and integration with automation and bioinformatics.

Parallelization Is Reshaping Oligonucleotide Development

The field is shifting from isolated sequence production toward highly parallel, digitally designed workflows. Array-based synthesis can support dense sequence libraries while reducing the physical handling associated with one-at-a-time production. Adoption is also being influenced by demand for faster design-build-test cycles, more complex assay panels, and scalable access to customized nucleic-acid materials. Key challenges remain, including shorter effective read lengths, deletion and substitution errors, batch-to-batch consistency, recovery of individual sequences, and the need for robust quality-control procedures.

Artificial Intelligence Connects Design, Synthesis, and Validation

Artificial intelligence is increasingly relevant across the workflow rather than only at the sequence-design stage. Machine-learning methods can help prioritize candidate sequences, identify problematic motifs, optimize codon or probe designs, and predict secondary-structure or synthesis-related risks. AI-assisted laboratory planning may improve array utilization, sample tracking, and quality-control triage, while sequence-analysis tools can help distinguish technical errors from biological variation. Reliable implementation still requires representative training data, experimental validation, transparent performance metrics, cybersecurity controls, and human oversight.

Regional Conditions Differ Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America benefits from established biotechnology infrastructure, strong academic-industry collaboration, and advanced laboratory automation. Europe combines substantial research capacity with rigorous chemical, biological, data, and product-governance requirements, while the European Union places particular emphasis on traceability and responsible innovation. Asia-Pacific is supported by expanding genomics activity, manufacturing capabilities, and research investment, although access and regulatory maturity vary across markets. Latin America is developing capabilities through universities, diagnostic programs, and agricultural biotechnology, with infrastructure and import dependence remaining practical constraints. The Middle East is building genomics and life-science capacity through national initiatives and specialized institutions. Africa presents important opportunities in infectious-disease surveillance, agriculture, and locally relevant research, but uneven laboratory infrastructure, procurement complexity, and specialist availability can limit deployment.

Cross-Group Dynamics Shape Standards, Access, and Collaboration

ASEAN economies reflect varied levels of research infrastructure, manufacturing depth, and regulatory development, making regional interoperability valuable. BRICS members span major scientific and industrial capabilities but differ substantially in procurement systems, standards, and access to specialized equipment. The European Union emphasizes harmonized governance, data protection, and quality systems. G7 members generally contribute advanced research networks, automation expertise, and translational capacity. GCC countries are investing in genomics, healthcare modernization, and research infrastructure, while local capability-building remains a central consideration. NATO members may benefit from established scientific collaboration and biosecurity coordination, although defense-related applications require careful governance, export-control awareness, and responsible-use safeguards.

Country Priorities Range From Infrastructure Expansion to Advanced Translation

The United States combines deep biotechnology research capacity, automation adoption, and translational activity. Canada has strengths in academic genomics and public research networks. The United Kingdom, France, Germany, Italy, and Spain contribute established molecular-biology communities, biomanufacturing capabilities, and structured regulatory environments, with national implementation differing by application. China is expanding genomic research, laboratory automation, and domestic supply-chain capabilities. Japan emphasizes precision, reliability, and advanced instrumentation, while South Korea combines biotechnology development with strong electronics and manufacturing expertise. India is broadening genomics, diagnostics, and biotechnology capacity while focusing on affordability and scale. Australia supports genomics research, agricultural applications, and geographically distributed scientific networks. Brazil and Mexico are developing applications in health, agriculture, and research, with infrastructure access and supply-chain resilience remaining important. Russia maintains scientific capabilities in selected molecular and biological fields, while collaboration, procurement, and regulatory conditions can affect technology access.

Prioritize Quality, Interoperability, and Use-Case-Focused Deployment

Industry leaders should begin with applications where parallel sequence generation creates a clear workflow advantage, then validate performance against defined accuracy, recovery, turnaround, and reproducibility criteria. They should establish orthogonal quality-control methods, document sequence-level error profiles, and align synthesis, purification, sequencing, and informatics systems through interoperable data standards. Partnerships with research institutions and specialized automation providers can accelerate method validation, but governance should address intellectual property, data security, biosecurity, and responsible-use screening. AI investments should be tied to measurable laboratory outcomes and supported by curated datasets, audit trails, and expert review. Regional operating models should also account for reagent availability, service continuity, regulatory obligations, and local technical training.

Methodology: Evidence-Based Synthesis of Technology and Operating Conditions

This executive summary is based on the supplied market definition, namely chip-based oligonucleotide synthesis, and a structured assessment of documented technology characteristics, application requirements, regional research conditions, policy environments, and operational constraints. The analysis distinguishes established capabilities from emerging use cases and avoids unsupported quantitative claims. Regional, group, and country observations are framed as qualitative comparisons of infrastructure, scientific activity, regulation, manufacturing, and access factors. Artificial-intelligence commentary focuses on documented workflow applications and implementation requirements rather than unverified performance claims.

Chip-Based Synthesis Will Advance Through Integrated, Governed Workflows

Chip-based oligonucleotide synthesis is positioned to support increasingly multiplexed and digitally managed biology workflows. Its progress will depend less on parallel synthesis alone than on the coordinated improvement of fidelity, sequence recovery, automation, analytics, supply resilience, and regulatory assurance. Organizations that combine carefully selected use cases with rigorous validation, interoperable systems, responsible AI, and regionally informed operating models will be better placed to translate the technology into dependable research and applied outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Chip-based Oligonucleotide Synthesis Market, by Product Type

  • 7.1. Introduction
  • 7.2. Dna Oligonucleotides
  • 7.3. Modified Oligonucleotides
    • 7.3.1. Locked Nucleic Acid
    • 7.3.2. Morpholino
    • 7.3.3. Peptide Nucleic Acid
  • 7.4. Rna Oligonucleotides

8. Chip-based Oligonucleotide Synthesis Market, by Technology

  • 8.1. Introduction
  • 8.2. Electrochemical
  • 8.3. Microfluidic Flow Based
  • 8.4. Photolithography
    • 8.4.1. Mask Based Photolithography
    • 8.4.2. Maskless Photolithography

9. Chip-based Oligonucleotide Synthesis Market, by Application

  • 9.1. Introduction
  • 9.2. Agriculture Biotechnology
  • 9.3. Diagnostics
  • 9.4. Genomics & Personalized Medicine
    • 9.4.1. Crispr Cas
    • 9.4.2. Microarray Analysis
    • 9.4.3. Next Generation Sequencing
  • 9.5. Research & Development
  • 9.6. Therapeutics

10. Chip-based Oligonucleotide Synthesis Market, by End User

  • 10.1. Introduction
  • 10.2. Academic And Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Diagnostic Laboratories
  • 10.5. Pharmaceutical And Biotechnology Companies

11. Chip-based Oligonucleotide Synthesis Market, by Scale

  • 11.1. Introduction
  • 11.2. Industrial Scale
  • 11.3. Laboratory Scale

12. Chip-based Oligonucleotide Synthesis Market, by Region

  • 12.1. Introduction
  • 12.2. Asia-Pacific
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Europe
  • 12.6. Middle East
  • 12.7. Africa

13. Chip-based Oligonucleotide Synthesis Market, by Group

  • 13.1. Introduction
  • 13.2. ASEAN
  • 13.3. GCC
  • 13.4. European Union
  • 13.5. BRICS
  • 13.6. G7
  • 13.7. NATO

14. Chip-based Oligonucleotide Synthesis Market, by Country

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. United Kingdom
  • 14.7. Germany
  • 14.8. France
  • 14.9. Russia
  • 14.10. Italy
  • 14.11. Spain
  • 14.12. China
  • 14.13. India
  • 14.14. Japan
  • 14.15. Australia
  • 14.16. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. Market Concentration Analysis, 2025
    • 15.2.1. Concentration Ratio (CR)
    • 15.2.2. Herfindahl Hirschman Index (HHI)
  • 15.3. Recent Developments & Impact Analysis, 2025
  • 15.4. Product Portfolio Analysis, 2025
  • 15.5. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Agilent Technologies, Inc.
  • 16.2. BioAutomation, Inc.
  • 16.3. CustomArray, Inc.
  • 16.4. Eurofins Genomics GmbH
  • 16.5. GenScript Biotech Corporation
  • 16.6. LC Sciences, LLC
  • 16.7. Merck KGaA
  • 16.8. Nuclera Nucleics Ltd
  • 16.9. Roche Sequencing Solutions, Inc.
  • 16.10. Thermo Fisher Scientific Inc.
  • 16.11. Twist Bioscience Corporation

17. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Chip-based Oligonucleotide Synthesis Market, Years Considered for the Study
  • FIGURE 2. Global Chip-based Oligonucleotide Synthesis Market, Research Design
  • FIGURE 3. Global Chip-based Oligonucleotide Synthesis Market, Research Framework
  • FIGURE 4. Global Chip-based Oligonucleotide Synthesis Market, Data Triangulation
  • FIGURE 5. Global Chip-based Oligonucleotide Synthesis Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2025 vs 2032 (%)
  • FIGURE 9. Global Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Chip-based Oligonucleotide Synthesis Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 11. Global Chip-based Oligonucleotide Synthesis Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Chip-based Oligonucleotide Synthesis Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 13. Global Chip-based Oligonucleotide Synthesis Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2025 vs 2032 (%)
  • FIGURE 15. Global Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Chip-based Oligonucleotide Synthesis Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 17. Global Chip-based Oligonucleotide Synthesis Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Chip-based Oligonucleotide Synthesis Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Chip-based Oligonucleotide Synthesis Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 20. Global Chip-based Oligonucleotide Synthesis Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Chip-based Oligonucleotide Synthesis Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Chip-based Oligonucleotide Synthesis Market Segmentation & Coverage
  • TABLE 2. Global Chip-based Oligonucleotide Synthesis Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 4. Global Dna Oligonucleotides Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Dna Oligonucleotides Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Dna Oligonucleotides Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Modified Oligonucleotides Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Modified Oligonucleotides Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Modified Oligonucleotides Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Locked Nucleic Acid Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Locked Nucleic Acid Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Locked Nucleic Acid Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Morpholino Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Morpholino Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Morpholino Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Peptide Nucleic Acid Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Peptide Nucleic Acid Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Peptide Nucleic Acid Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Rna Oligonucleotides Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Rna Oligonucleotides Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Rna Oligonucleotides Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 23. Global Electrochemical Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Electrochemical Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Electrochemical Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Microfluidic Flow Based Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 27. Global Microfluidic Flow Based Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 28. Global Microfluidic Flow Based Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 29. Global Photolithography Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 30. Global Photolithography Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 31. Global Photolithography Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 32. Global Mask Based Photolithography Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 33. Global Mask Based Photolithography Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 34. Global Mask Based Photolithography Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 35. Global Maskless Photolithography Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 36. Global Maskless Photolithography Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 37. Global Maskless Photolithography Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 38. Global Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 39. Global Agriculture Biotechnology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 40. Global Agriculture Biotechnology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 41. Global Agriculture Biotechnology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 42. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 43. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 44. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 45. Global Genomics & Personalized Medicine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 46. Global Genomics & Personalized Medicine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 47. Global Genomics & Personalized Medicine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 48. Global Crispr Cas Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 49. Global Crispr Cas Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 50. Global Crispr Cas Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 51. Global Microarray Analysis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 52. Global Microarray Analysis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 53. Global Microarray Analysis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 54. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 55. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 56. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 57. Global Research & Development Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 58. Global Research & Development Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 59. Global Research & Development Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 60. Global Therapeutics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 61. Global Therapeutics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 62. Global Therapeutics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 63. Global Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 64. Global Academic And Research Institutes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 65. Global Academic And Research Institutes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 66. Global Academic And Research Institutes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 67. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 68. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 69. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 70. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 71. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 72. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 73. Global Pharmaceutical And Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 74. Global Pharmaceutical And Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 75. Global Pharmaceutical And Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 76. Global Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 77. Global Industrial Scale Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 78. Global Industrial Scale Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 79. Global Industrial Scale Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 80. Global Laboratory Scale Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 81. Global Laboratory Scale Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 82. Global Laboratory Scale Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 83. Global Chip-based Oligonucleotide Synthesis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 84. Asia-Pacific Chip-based Oligonucleotide Synthesis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 85. Asia-Pacific Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 86. Asia-Pacific Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 87. Asia-Pacific Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 88. Asia-Pacific Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 89. Asia-Pacific Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 90. Asia-Pacific Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 91. Asia-Pacific Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 92. Asia-Pacific Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 93. North America Chip-based Oligonucleotide Synthesis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 94. North America Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 95. North America Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 96. North America Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 97. North America Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 98. North America Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 99. North America Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 100. North America Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 101. North America Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 102. Latin America Chip-based Oligonucleotide Synthesis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 103. Latin America Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 104. Latin America Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 105. Latin America Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 106. Latin America Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 107. Latin America Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 108. Latin America Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 109. Latin America Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 110. Latin America Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 111. Europe Chip-based Oligonucleotide Synthesis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 112. Europe Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 113. Europe Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 114. Europe Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 115. Europe Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 116. Europe Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 117. Europe Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 118. Europe Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 119. Europe Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 120. Middle East Chip-based Oligonucleotide Synthesis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 121. Middle East Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 122. Middle East Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 123. Middle East Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 124. Middle East Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 125. Middle East Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 126. Middle East Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 127. Middle East Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 128. Middle East Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 129. Africa Chip-based Oligonucleotide Synthesis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 130. Africa Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 131. Africa Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 132. Africa Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 133. Africa Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 134. Africa Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 135. Africa Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 136. Africa Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 137. Africa Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 138. Global Chip-based Oligonucleotide Synthesis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 139. ASEAN Chip-based Oligonucleotide Synthesis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 140. ASEAN Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 141. ASEAN Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 142. ASEAN Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 143. ASEAN Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 144. ASEAN Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 145. ASEAN Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 146. ASEAN Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 147. ASEAN Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 148. GCC Chip-based Oligonucleotide Synthesis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 149. GCC Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 150. GCC Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 151. GCC Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 152. GCC Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 153. GCC Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 154. GCC Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 155. GCC Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 156. GCC Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 157. European Union Chip-based Oligonucleotide Synthesis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 158. European Union Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 159. European Union Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 160. European Union Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 161. European Union Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 162. European Union Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 163. European Union Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 164. European Union Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 165. European Union Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 166. BRICS Chip-based Oligonucleotide Synthesis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 167. BRICS Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 168. BRICS Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 169. BRICS Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 170. BRICS Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 171. BRICS Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 172. BRICS Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 173. BRICS Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 174. BRICS Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 175. G7 Chip-based Oligonucleotide Synthesis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 176. G7 Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 177. G7 Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 178. G7 Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 179. G7 Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 180. G7 Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 181. G7 Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 182. G7 Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 183. G7 Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 184. NATO Chip-based Oligonucleotide Synthesis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 185. NATO Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 186. NATO Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 187. NATO Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 188. NATO Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 189. NATO Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 190. NATO Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 191. NATO Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 192. NATO Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 193. Global Chip-based Oligonucleotide Synthesis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 194. United States Chip-based Oligonucleotide Synthesis Market Size, 2017-2032 (USD Million)
  • TABLE 195. United States Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 196. United States Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 197. United States Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 198. United States Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 199. United States Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 200. United States Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 201. United States Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 202. United States Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 203. Canada Chip-based Oligonucleotide Synthesis Market Size, 2017-2032 (USD Million)
  • TABLE 204. Canada Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 205. Canada Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 206. Canada Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 207. Canada Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 208. Canada Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 209. Canada Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 210. Canada Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 211. Canada Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 212. Mexico Chip-based Oligonucleotide Synthesis Market Size, 2017-2032 (USD Million)
  • TABLE 213. Mexico Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 214. Mexico Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 215. Mexico Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 216. Mexico Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 217. Mexico Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 218. Mexico Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 219. Mexico Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 220. Mexico Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 221. Brazil Chip-based Oligonucleotide Synthesis Market Size, 2017-2032 (USD Million)
  • TABLE 222. Brazil Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 223. Brazil Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 224. Brazil Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 225. Brazil Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 226. Brazil Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 227. Brazil Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 228. Brazil Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 229. Brazil Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 230. United Kingdom Chip-based Oligonucleotide Synthesis Market Size, 2017-2032 (USD Million)
  • TABLE 231. United Kingdom Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 232. United Kingdom Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 233. United Kingdom Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 234. United Kingdom Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 235. United Kingdom Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 236. United Kingdom Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 237. United Kingdom Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 238. United Kingdom Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 239. Germany Chip-based Oligonucleotide Synthesis Market Size, 2017-2032 (USD Million)
  • TABLE 240. Germany Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 241. Germany Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 242. Germany Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 243. Germany Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 244. Germany Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 245. Germany Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 246. Germany Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 247. Germany Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 248. France Chip-based Oligonucleotide Synthesis Market Size, 2017-2032 (USD Million)
  • TABLE 249. France Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 250. France Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 251. France Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 252. France Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 253. France Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 254. France Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 255. France Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 256. France Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 257. Russia Chip-based Oligonucleotide Synthesis Market Size, 2017-2032 (USD Million)
  • TABLE 258. Russia Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 259. Russia Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 260. Russia Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 261. Russia Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 262. Russia Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 263. Russia Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 264. Russia Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 265. Russia Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 266. Italy Chip-based Oligonucleotide Synthesis Market Size, 2017-2032 (USD Million)
  • TABLE 267. Italy Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 268. Italy Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 269. Italy Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 270. Italy Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 271. Italy Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 272. Italy Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 273. Italy Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 274. Italy Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 275. Spain Chip-based Oligonucleotide Synthesis Market Size, 2017-2032 (USD Million)
  • TABLE 276. Spain Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 277. Spain Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 278. Spain Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 279. Spain Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 280. Spain Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 281. Spain Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 282. Spain Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 283. Spain Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 284. China Chip-based Oligonucleotide Synthesis Market Size, 2017-2032 (USD Million)
  • TABLE 285. China Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 286. China Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 287. China Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 288. China Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 289. China Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 290. China Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 291. China Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 292. China Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 293. India Chip-based Oligonucleotide Synthesis Market Size, 2017-2032 (USD Million)
  • TABLE 294. India Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 295. India Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 296. India Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 297. India Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 298. India Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 299. India Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 300. India Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 301. India Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 302. Japan Chip-based Oligonucleotide Synthesis Market Size, 2017-2032 (USD Million)
  • TABLE 303. Japan Chip-based Oligonucleotide Synthesis Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 304. Japan Chip-based Oligonucleotide Synthesis Market Size, by Modified Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 305. Japan Chip-based Oligonucleotide Synthesis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 306. Japan Chip-based Oligonucleotide Synthesis Market Size, by Photolithography, 2017-2032 (USD Million)
  • TABLE 307. Japan Chip-based Oligonucleotide Synthesis Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 308. Japan Chip-based Oligonucleotide Synthesis Market Size, by Genomics & Personalized Medicine, 2017-2032 (USD Million)
  • TABLE 309. Japan Chip-based Oligonucleotide Synthesis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 310. Japan Chip-based Oligonucleotide Synthesis Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 311. Australia Chip-based Oligonucleotide Synthesis Market Size, 2017-2032 (USD Million)
  • TABLE 312. Australia Chip-